Markets
paper Chinese yuan in piles
(Shutterstock)

The market wants more from China

The stock rally continued when China’s onshore market reopened, but traders were disappointed at the lack of further policies to save China’s sluggish economy

China’s market had an epic rally after China’s central bank unveiled a slew of monetary stimulus measures in September. 

A big question remained, though: how long will it last? We may have gotten some clues as the market reopened on Tuesday after a seven-day National Day holiday from October 1 to 7, as the policy-driven rally seemed to have lost some momentum. 

The CSI 300, which tracks the top 300 stocks traded on the Shanghai Stock Exchange and the Shenzhen Stock Exchange, surged nearly 11% during the market open on Tuesday. But the index eased some gains throughout the day to finish 6.1% up.

Meanwhile, Hong Kong’s benchmark index, Hang Seng, slumped 5.6% on Tuesday, wiping out all gains during the National Day holiday (the Hong Kong stock exchange was closed only on October 1).

The decline was partly due to a disappointing presser from China’s top economic planner. After late September’s stimulus — which included rate cuts, lower existing mortgage rates, lower required reserve ratio, and a 800-million-yuan liquidity support for the stock market — traders were expecting more details on fiscal stimulus from the government to get the economy back on track. That includes spending incentives, special bonds, and support for “new college graduates, migrant workers, the unemployed, elderly, and disabled,” analysts said.

But at its first post-holiday meeting, the National Development and Reform Commission (NDRC) “did not provide any more details around the shape and size of the fiscal support that has been announced,” Deutsche Bank analysts wrote in a note.

Wall Street was expecting somewhere between 2 trillion and 3 trillion yuan in fiscal packages. The NDRC, however, announced a modest 200 billion yuan (about $28.3 billion), 100 billion yuan of which was going to construction projects. 

Some China watchers said that the announcement wasn’t surprising, given how Chinese government agencies usually behave. NDRC’s main goal was likely not to meet the market where it was, but more to send a signal to top government officials about the intent to target the economy, notwithstanding concrete policies.

Still, the CSI 300 finished at another record high. ETFs that track China megacaps gained over 30% in the past month, outperforming the S&P 500.

The market vs. the economy

Broadly, analysts agree that the booming stock market doesn’t change the fundamentals of China’s economy, which has been on a downhill path since 2021. But degrees of optimism over the market rally differ. 

Goldman Sachs upgraded its call on Chinese offshore stocks (Chinese companies that trade in Hong Kong or the US) to overweight on October 7 and shifted its tactical preference from H-shares (that are traded in Hong Kong dollars) to A-shares (that are traded in Chinese yuan), saying in a note to clients that these stocks are more directly exposed to stock market stimulus and retail investors’ participation.

Indeed, the retail sentiment alone, independent of fiscal measures, was strong in China. State media reported a 4x to 6x surge in the number of new brokerage accounts, mostly from young people. ETF inflows and margin financing activities also rose. Shares of China’s brokerage software like Hithink Flush and East Money have more than doubled since September 23.

But others see the Chinese economy as a deeper problem. Adam Wolfe, emerging markets economist at Absolute Strategy Research, distinguished between the stimulus measures for the real economy and the stock market, calling the former “mostly incremental, small, and inconsequential,” while the latter was “new, unlimited, and significant.” 

Olivier d’Assier, Head of APAC, Investment Decision Research at SimCorp, said that China’s banking system is “teetering on the verge of collapse,” and the announced stimulus was not enough.

“It is $59 trillion in size and only $142 billion was announced to recapitalize it — compare this to a US banking system of $23.4 trillion, much better diversified than China’s, and where the Fed spent $475 billion to recapitalize it during the GFC,” he said.

“As for the market, this is a policy-driven rally. It won’t last and it won’t change the equation for investors — most of whom will not have bought at the bottom,” d’Assier added.

More Markets

See all Markets

Oil-sensitive travel stocks pop following Iran state media reporting on potential war resolution

Travel stocks are surging on Tuesday as oil prices fall following reports from Iranian state media that Iran's President Masoud Pezeshkian said the country has "the necessary will to end this war," but would only do so with guarantees that "prevent the recurrence of aggression."

The war has sent oil prices and refining margins surging this month, causing airlines and cruise lines to cut profit forecasts despite reported high demand.

Following Tuesday’s update, shares of the big four US airlines (Delta Air Lines, United Airlines, American Airlines, and Southwest Airlines) all climbed, along with smaller rivals including JetBlue. US airlines have stopped fuel hedging in recent years, increasing their exposure to upward swings in oil prices.

Cruise stocks also rallied, with Carnival and Norwegian up more than 6% and Royal Caribbean up about 5%.

markets

The FDA is expected to lift restrictions on certain peptides, the NYT reports

The Food and Drug Administration is expected to lift restrictions on certain peptides, allowing the experimental, often injectable substances to be sold by compounding pharmacies, The New York Times reported Tuesday.

The potential move was previously reported by The Wall Street Journal, and teased by Health Secretary Robert F. Kennedy Jr. on the “Joe Rogan Experience” podcast in late February.

Peptides have boomed in popularity recently, with search interest for “peptides” surpassing “ozempic” this month. Many of them are currently understudied and not approved for human use, a rule consumers are able to bypass by purchasing them from suppliers that sell them for, ostensibly, research purposes only.

As reports of the FDA changing its stance of peptides mount, consumer health companies like Hims & Hers and Superpower have been getting ready to roll out their peptide offerings as soon as they get the FDA's blessing.

Peptides have boomed in popularity recently, with search interest for “peptides” surpassing “ozempic” this month. Many of them are currently understudied and not approved for human use, a rule consumers are able to bypass by purchasing them from suppliers that sell them for, ostensibly, research purposes only.

As reports of the FDA changing its stance of peptides mount, consumer health companies like Hims & Hers and Superpower have been getting ready to roll out their peptide offerings as soon as they get the FDA's blessing.

markets

Memory stocks bounce as Bernstein analyst calls TurboQuant fears “overdone”

Memory stocks rose Tuesday, after Bernstein analysts called the recent panic over Google’s TurboQuant AI algorithm “overdone.”

Bernstein analyst Mark Newman wrote:

“[Hard disk drive] and Memory stocks have sold off significantly due in part to fears from Google’s TurboQuant report. This however, should have zero impact on HDD demand and negligible impact on NAND demand. Given the stock sell-off we see this as an attractive entry point for Seagate Technology Holdings, Western Digital and Sandisk’s and upgrade WDC to Outperform.”

All three stocks were up early Tuesday, as was memory chip maker Micron.

Todays rally stands in stark contrast to the pummeling these shares have endured over the last week, after Google Research published a technical paper on March 24 detailing its TurboQuant AI algorithm, which compresses the amount of data associated with AI operations without affecting the accuracy of AI models.

That was seen as a threat to surging AI demand for memory storage, which has supercharged prices for memory chips and memory-related stocks over the last year.

markets

Constellation tumbles after posting underwhelming guidance, failing to announce new data center deals

AI power trade Constellation Energy tumbled early Tuesday after issuing an investor day update the market seemed to find unsatisfactory.

The company introduced full-year 2026 operating earnings guidance of between $11 and $12 a share, the midpoint of which is shy of consensus expectations for $11.73, according to FactSet.

Over at Barron’s, Avi Salzman suggested that the company’s failure to unveil any new data center deals as part of the festivities is also adding the the sell-off. He wrote:

“Constellation CEO Joe Dominguez said at the event that he anticipates signing major new deals to provide power to tech companies, but doesn’t want to announce anything too early given the increasing spotlight on data centers today and some changing regulations.

‘I recognize that the last time we spoke, I indicated that we expected to be done with an important transaction by this call, but we’re not ready to announce anything today,’ Dominguez said.

‘There is clearly more scrutiny on data center development,’ he added.”

It’s clear that growing public pushback on data centers is becoming a limiting factor in the AI investment binge.

Over at Barron’s, Avi Salzman suggested that the company’s failure to unveil any new data center deals as part of the festivities is also adding the the sell-off. He wrote:

“Constellation CEO Joe Dominguez said at the event that he anticipates signing major new deals to provide power to tech companies, but doesn’t want to announce anything too early given the increasing spotlight on data centers today and some changing regulations.

‘I recognize that the last time we spoke, I indicated that we expected to be done with an important transaction by this call, but we’re not ready to announce anything today,’ Dominguez said.

‘There is clearly more scrutiny on data center development,’ he added.”

It’s clear that growing public pushback on data centers is becoming a limiting factor in the AI investment binge.

markets

CoreWeave jumps after closing unique financing deal to borrow $8.5 billion backed by its chips and Meta’s AI compute purchases

Shares of CoreWeave are spiking on Tuesday after the company announced that it closed an $8.5 billion loan backed by its chips and what Meta is willing to pay to use them.

Last September, the neocloud reached an agreement to provide $14.2 billion worth of AI compute to the social media giant.

CoreWeave said the loan agreement is “the first investment-grade rated financing secured by HPC infrastructure and an associated customer contract.”

These terms helped to reduce CoreWeave’s cost of borrowing: this facility includes a floating rate (SOFR plus 2.25%, or about 5.9%) as well as a fixed rate tranche (at 5.9%). Last July, CoreWeave raised fixed-rate debt with a coupon of 9%.

In a world where Oracle’s five-year credit default swap spreads recently exceeded their 2008 peak, it’s nice to get some positive debt-related news in the AI realm.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.